Grant: Collaborative Health Research Projects
McGill University
$79,332.00
Development of a mechanically biomcompatible hip replacement implant with Ti-6Al-4V open-cell microlattice architecture
FY 2015-16
Summary
Total hip arthroplasty (THA) is an ordinary surgery that involves the removal and replacement of the damaged hip joint with
an artificial femoral head and acetabular cup. Although the operation is generally successful, the service life of existing
implants is generally limited to 15 years, after which another surgery is required. It is estimated that by 2030 the demand for
primary THA will grow by 174%. Among them, those requiring revision are projected to increase by 137%.
Revision surgery presents more complications than a first-time THA. Factors that make the procedure complex include the
removal of the failed components, the quality of the existing bone, the reconstruction of bone tissue, and the fixing of the
new implant to the bone. Among these, the quality of the bone surrounding the old implant is crucial to the success of a
revision surgery. If the remaining bone is unable to provide a mechanical foundation for the new implant, the prosthesis
cannot be properly fixed to the bone. The ability to prevent bone resorption in the long term is one major bottle neck of
existing THA implants. This research program proposes the development of an innovative THA implant that allows the
surrounding bone tissue to remodel in the long term.
The implant will impact Canadian health and Canada in a multitude of ways. First, the treatment of patients requiring primary
and revision THA surgery will be enhanced. This will dramatically improve their long-term autonomy, health and standard of
life. Second, the implant will lower the need of revision surgery, with a drastic drop in health care costs. Third, when THA
revision is needed, the implant capacity of preserving the host bone in the long term will make revision surgery as successful
as primary THA.
Program
Collaborative Health Research Projects
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
462501-2014
Name nom
Pasini, Damiano
Department département
Mechanical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2014
Award amount
79332
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2
Nb partie
3
Application title
Development of a mechanically biomcompatible hip replacement implant with Ti-6Al-4V open-cell microlattice architecture
Keyword
NSERC
Application summary
Total hip arthroplasty (THA) is an ordinary surgery that involves the removal and replacement of the damaged hip joint with
an artificial femoral head and acetabular cup. Although the operation is generally successful, the service life of existing
implants is generally limited to 15 years, after which another surgery is required. It is estimated that by 2030 the demand for
primary THA will grow by 174%. Among them, those requiring revision are projected to increase by 137%.
Revision surgery presents more complications than a first-time THA. Factors that make the procedure complex include the
removal of the failed components, the quality of the existing bone, the reconstruction of bone tissue, and the fixing of the
new implant to the bone. Among these, the quality of the bone surrounding the old implant is crucial to the success of a
revision surgery. If the remaining bone is unable to provide a mechanical foundation for the new implant, the prosthesis
cannot be properly fixed to the bone. The ability to prevent bone resorption in the long term is one major bottle neck of
existing THA implants. This research program proposes the development of an innovative THA implant that allows the
surrounding bone tissue to remodel in the long term.
The implant will impact Canadian health and Canada in a multitude of ways. First, the treatment of patients requiring primary
and revision THA surgery will be enhanced. This will dramatically improve their long-term autonomy, health and standard of
life. Second, the implant will lower the need of revision surgery, with a drastic drop in health care costs. Third, when THA
revision is needed, the implant capacity of preserving the host bone in the long term will make revision surgery as successful
as primary THA.